Ionis Pharmaceuticals, Inc. (IONS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 37.85 |
| Open | 38.04 |
| Bid | 33.11 x 800 |
| Ask | 39.27 x 900 |
| Day's Range | 36.69 - 38.92 |
| 52 Week Range | 25.04 - 44.42 |
| Volume | |
| Avg. Volume | 1,093,550 |
| Market Cap | 5.22B |
| Beta (5Y Monthly) | 0.77 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 |
| Earnings Date | Aug 02, 2022 - Aug 08, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 47.33 |
- Simply Wall St.
What Kind Of Shareholders Hold The Majority In Ionis Pharmaceuticals, Inc.'s (NASDAQ:IONS) Shares?
A look at the shareholders of Ionis Pharmaceuticals, Inc. ( NASDAQ:IONS ) can tell us which group is most powerful...
- Zacks
Ionis (IONS), AstraZeneca's Amyloidosis Drug Meets Study Goals
Ionis (IONS), along with partner AstraZeneca, reports positive data from a phase III study, which is evaluating eplontersen in hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN).
- Zacks
Ionis' (IONS) Angelman Syndrome Drug Gets FDA's Orphan Tag
The FDA grants orphan drug and rare pediatric disease designations to Ionis' (IONS) ION582 for treating Angelman syndrome. These designations will help incentivize development of the candidate.
© 2022 Yahoo. All rights reserved.
